Stocks and Investing
Stocks and Investing
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
[ Fri, Aug 02nd 2024
] - WOPRAI
Conor McNamara Maintained (BIO) at Buy with Decreased Target to $401 on, Aug 2nd, 2024
Conor McNamara of RBC Capital, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Decreased Target from $402 to $401 on, Aug 2nd, 2024.
Conor has made no other calls on BIO in the last 4 months.
There is 1 other peer that has a rating on BIO. Out of the 1 peers that are also analyzing BIO, 0 agree with Conor's Rating of Hold.
This is the rating of the analyst that currently disagrees with Conor
- Dan Leonard of "UBS" Maintained at Strong Buy with Decreased Target to $385 on, Wednesday, May 8th, 2024
Contributing Sources